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Neurological soft signs have been observed in patients with
schizophrenia and their relatives. However, it has not been
considered whether the increased rates of neurological soft
signs are related to measures of psychosis proneness in
thegeneralpopulation.Wetestedthishypothesisinagroup
of normal volunteers (n = 28) who scored highly for positive
schizotypywhenassessedonlineandacontrolgroup(n= 33)
whoscoredbelowthemean.Comparedwiththecontrols,high
psychosis-prone individuals showed significantly higher
Total and Other Soft Signs subscale scores on the Neurol-
ogical Evaluation Scale. It appears that soft signs are also
associated with psychosis proneness when measured in the
general population, which suggests that soft signs are dis-
tributed along a continuum of risk for schizophrenia.
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Introduction
There is an extensive literature reporting increased
rates of neurological soft signs in patients with schizo-
phrenia.
1,2 ‘‘Soft’’ signs are minor, nonlocalizable, objec-
tive abnormalities that are thought to reflect damage in
connections between subcortical and cortical areas or be-
tween cortical areas.
3–5 In contrast, ‘‘hard’’ neurological
signs can be linked to specific areas of neuroanatomical
damage.
6 Some researchers believe neurological soft
signs represent a developmental lag rather than a fixed
abnormality.
7
Patients with schizophrenia have frequently been re-
ported to display more neurological soft signs when com-
pared with controls
4,8–12 and other patient groups,
13–15
even after controlling for effects of drug treatment.
16
Neurological soft signs have also been found with in-
creased frequency in relatives of those with schizophre-
nia,
4,17–20 offspring of those with schizophrenia,
21,22
and in those considered at high genetic risk for develop-
ing schizophrenia in the future.
22,23 If neurological soft
signs characterize those at increased genetic risk for
schizophrenia, it might be predicted that they would
also appear with increased frequency in schizotypy, a
putative measure of psychosis liability. Determining
whether neurological soft signs are related to a normally
distributed marker of psychosis proneness or schizotypy
in the general population would demonstrate whether
they are detectable along a continuum of risk. We hy-
pothesized that those who scored highly on positive
schizotypy would present with higher soft sign scores
as measured by the Neurological Evaluation Scale.
24
Method
Participants
The participants were university student volunteers
selected on the basis of their responses to the Unusual
Experiences subscale from the Oxford Liverpool Inven-
tory of Feelings and Experiences (O-LIFE)
25 and the
Launay-Slade Hallucination Scale (LSHS),
26 which
were placed on a university intranet. Both of these ques-
tionnaires are considered valid measures of schizotypy
or psychosis proneness. Two subgroups of participants
wereassessedatinterview:a‘‘highpsychosis-prone’’group
(n = 28), who scored above 1 standard deviation from
the mean on both scales, and a control group (n = 33),
who scored at or below the mean. The 2 groups did not
differsignificantlyondemographicvariables:thehighpro-
neness group consisted of 15 males (54%), with a mean
ageof22.5(SD=5.7)years,andthecontrolgroupconsisted
of16males(49%),withameanage25.4(SD=10.5)years.
In the sample 95% of participants were right-handed.
Measures
Participants were evaluated with the Neurological Eval-
uation Scale (NES).
24 The NES measures 4 neurological
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573domains: Sensory Integration, Motor Coordination,
Sequencing of Complex Motor Acts, and Other Soft
Signs. There are 28 items on the NES. The following
items were assessed for both the left- and right-handed
subjects: Stereognosis, Graphesthesia, Fist-Ring Test,
Fist-Edge-Palm Test, Rapid Alternating Movements,
Finger-Thumb Opposition, and Mirror Movements.
Participants also completed a questionnaire about
substance use.
27
Procedure
The study received ethical approval as part of a larger
projectexaminingthecorrelatesofschizotypyinahealthy
population. Participants gave informed written consent
and were assured of anonymity and confidentiality of
the data being collected.
Participants were contacted by e-mail to request their
participation in the study after they had been identified
through the online completion of the O-LIFE and the
LSHS. Participants completed the NES in the order de-
scribed in Buchanan and Heinrichs.
24 Assessments were
performed by 2 raters who were blind to the subgroup
status of participants. Interrater reliability was estab-
lished prior to the start of the study using different par-
ticipants from the experimental sample. First, the raters
both completed assessments of 5 participants at the same
time to establish that they had a similar understanding
and appreciation of the rating scales for each item. Sec-
ond, the NES was completed independently by the 2
raters on 5 individuals, with scores being compared after
each participant, until both raters produced the same
results. Finally, the 2 raters completed the assessment
on the same individual, who was well versed on soft signs
assessments and well acquainted with the NES, to ensure
that the administration of instructions and scale was
identical. As a post hoc check, the scores for the 2 raters
in the experimental sample were compared using a series
of independent t-tests: there were no significant differen-
ces in total or subscale scores.
Cards were produced with rhythms for the Rhythm
Tapping tests (A and B) and the Audio-Visual Integra-
tion tests to ensure they were standardized. For the Ster-
eognosis test participants were asked to identify a button,
a paper clip, a pen cap, and an elastic band. Two
items were identified in each hand. The administration
of the NES tests took approximately 30 minutes to
complete.
Results
For the 28 participants in the high proneness group and
33 participants in the control group, the subscales and
total score from the NES approximated to a normal
distribution with the exception of the Complex Motor
Skills subscale, which required a log transformation to
normalize the spread of the scores. Parametric analyses
were used to compare group means.
Drug Use, Schizotypy, and Soft Signs
The number of substances people had used recreationally
varied between 0 and 6. Substances that participants had
used were as follows (in order of frequency of use): can-
nabis (69%), amphetamines (22%), hallucinogens (16%),
cocaine (15%), sedatives, hypnotics, and tranquilizers
(13%), and solvents (6%). Regularity of use data was
only available for cannabis consumption; the reported
rates of use were as follows: few times each week
(29%), about once a week (6%), a few times each month
(3%), about once a month (11%), a few times each year
(26%),less thanonceayear(17%),and onlyonce ortwice
(9%).Therewasnoassociationbetweenregularityofcan-
nabis use and schizotypy group (v
2 = 3.79, df = 5, not sig-
nificant [NS]). There was also no association between
cannabis use and schizotypy group (v
2 = 0.74, df = 1,
NS). The relationship between cannabis use and schizo-
typy has been commented on elsewhere.
27 Cannabis use,
age when first used, and frequency of use were unrelated
to the presence of neurological soft signs. There was
a negative correlation between the Motor Coordination
subscaleandthenumberofrecreationaldrugspeoplehad
tried(rho=0.335,n=61,p=.008),indicatingthosewith
low scores on the Motor Coordination subscale had used
more recreational drugs.
Schizotypy Group and Soft Signs
The means and standard deviations for the 2 groups on
the total score and subscales from the NES are reported
in Table 1. A series of independent t-tests were run to ex-
amine whether the 2 groups differed in their levels of
reported neurological soft signs: the soft sign total and
subscales were the dependent variables, and the prone-
ness group was the independent variable. Due to the
numberofmultiplecomparisons,aBonferronicorrection
was adopted with alpha set to 1%. The t values and the
probability levels for the 2 groups are shown in Table 1.
The high psychosis-prone group showed higher scores on
the total from the NES and the Other SoftSigns subscale.
A logistic regression model was used to determine
whether the total from the NES or the subscales statisti-
callypredictedpsychosispronenessgroup.Theresultsare
displayed in Table 2. The total score from the NES was
entered into a model alone, due to its high correlation
with the subscales. The total NES score significantly pre-
dicted psychosis proneness group using an enter method
of variable selection. The subscales from the NES were
entered into a separate logistic regression model using
a stepwise method variable selection. The subscale that
successfully predicted psychosis proneness group was
the Other Soft Signs subscale. The results from this anal-
ysis can be seen in the second row of Table 2.
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Neurological soft signs were examined in a group of
healthy volunteers selected according to their positive
schizotypy score, as measured by the Unusual Experien-
ces subscale from the O-LIFE
25 and the LSHS.
26 The
high psychosis-prone individuals showed more soft signs
overall and on the Other Soft Signs subscale. From an
examination of the means for the remaining subscales
from the NES, the group differences occurred in the pre-
dicted direction, although they did not reached signifi-
cance. Using 2 separate regression models, the total
from the NES and the Other Soft Signs subscales signif-
icantly predicted psychosis proneness group.
A number of studies have used the Neurological
Evaluation Scale in samples of patients with schizophre-
nia; some produced results that support the data from
the current study. Ismail et al.
28 reported that patients
with schizophrenia and their siblings scored higher
than normal controls on the Soft Signs Total, as well
as the Sensory Integration and Motor Functioning sub-
scales. Additionally, patients with schizophrenia have
been reported to score higher than at-risk patients,
who in turn scored higher than controls on the Soft Signs
Total, Sensory Integration, and Other Soft Signs.
29
Arango et al.
30 reported that the Other Soft Signs
subscale was able to correctly classify a greater number
of patients and controls to their true group than the
other subscales from the NES. Taken together these pre-
vious studies and the current results suggest that the
Other Soft Signs subscale may be particularly sensitive
in identifying those with schizophrenia or a proneness
to it.
Griffiths et al.
18 suggested that the presence of soft
signs in relatives increases with the potential genetic
loading (ie, greater incidence of schizophrenia in a family
increases the presence of soft signs). Furthermore,
Gourion et al.
31 reported that the Total Soft Signs score
could be used to distinguish relatives who were thought
tobe carriers ofthe genetic vulnerability toschizophrenia
from those who were not. This suggests that the presence
of neurological soft signs may be indicative of being
a ‘‘gene-carrier’’ for psychosis. It is not possible, on
the information available, to determine whether the
participants in the current study are gene-carriers for
schizophrenia. However, a high score on a schizotypal
personality questionnaire is considered a phenotypic
marker for possible development of schizophrenia.
eg,32,33
However, the results from Lawrie et al.
29 may suggest
that soft signs are not an indicator of genetic risk specif-
ically for psychosis. Other causes of soft signs may be low
birth weight
34,35 and obstetric complications.
36 Obstetric
complications may be a more significant factor for males
at risk for schizophrenia,
37 or for leading to soft signs
in those at genetic risk for developing schizophrenia.
38
Additionally, childhood illnesses such as whooping
cough, meningitis, and tuberculosis have been associated
with soft signs in adulthood.
39 At the very least, these
studies suggest that the relationship between soft signs
and schizophrenia is not a simple one, with many medi-
ating variables being implicated.
Table 1. The Means (and Standard Deviations) for the High Proneness and Control Participants on the Total and Subscales from
the Neurological Evaluation Scale
High Proneness Group (n = 28) Control Group (n = 33)
Mean (SD) Mean (SD) t value (df = 59) Signiﬁcance
Soft Signs Total 16.57 (5.55) 13.37 (4.95) 2.39 .01
Sensory Integration 2.18 (1.56) 1.76 (1.54) 1.06 .15
Motor Coordination 1.54 (1.43) 1.42 (1.44) .30 .38
Complex Motor Skills 2.14 (2.24) 1.64 (1.69) 1.01 .16
Other Soft Signs 7.07 (3.40) 5.18 (2.96) 2.32 .01
Table 2. The Logistic Regression Results for Predicting Psychosis Proneness Group From the Total Score and Subscales from
the Neurological Evaluation Scale
95% Conﬁdence Interval
Beta Wald Signiﬁcance Odds Ratio Lower Upper
Soft Signs Total
a 0.12 4.98 .03 0.89 0.80 0.99
Other Soft Signs
b 0.19 4.75 .03 0.83 0.70 .98
Note: df = 1.
aEnter method of variable selection used.
bStepwise method of variable selection used.
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Neurological Soft Signs and Psychosis PronenessSome clarification of the intermediate variables
may result from examining the genes associated with
soft signs. For example, Lautenschlager et al.
40 reported
that the neurological soft signs were associated with
apolipoprotein E gene (which has been implicated in
Alzheimer disease
41), age, and cognitive performance.
With the increasing interest in the functional effects of
single nucleotide polymorphisms, it would be beneficial
to determine whether genes implicated in the dopamine
and glutamate pathways confer risk for the presence of
neurological soft signs.
Acknowledgments
Some of the data described in this paper was presented
at the Biennial Winter Workshop on Schizophrenia,
Davos, Switzerland, 2004. This project was funded by
the Stanley Medical Research Foundation.
References
1. Dazzan P, Murray RM. Neurological soft signs in first
episode psychosis: a systematic review. Br J Psychiatry.
2002;43:s50–s57.
2. Wolff AL, O’Driscoll GA. Motor deficits and schizophrenia:
the evidence from neuroleptic-naı ¨ve patients and populations
at risk. J Psychiatry Neurosci. 1999;24:304–314.
3. Kennard MA. Value of equivocal signs in neurologic diagno-
sis. Neurology. 1960;10:753–764.
4. Rossi A, de Cataldo S, di Michelle V, et al. Neurological soft
signs in schizophrenia. Br J Psychiatry. 1990;157:735–739.
5. Gupta S, Andreasen NC, Arndt S, et al. Neurological soft
signs in neuroleptic-naive and neuroleptic-treated schizo-
phrenic patients and in normal comparison subjects. Am J
Psychiatry. 1995;152:191–196.
6. Woods BT, Kinney DK, Yurgelun-Todd DA. Neurological
‘‘hard’’ signs and family history of psychosis in schizophrenia.
Biol Psychiatry. 1991;30:806–816.
7. Blondis TA, Snow JH, Accardo PJ. Integration of soft signs
in academically normal and academically at-risk children.
Pediatrics. 1990;85:421–425.
8. Venkatasubramanian G, Latha V, Gangadhar BN, et al.
Neurological soft signs in never treated schizophrenia. Acta
Psychiatr Scand. 2003;108:144–146.
9. Flyctt L, Sydow O, Bjerkenstadt L, Edman G, Rydin E,
Wiesel F-A. Neurological signs and psychomotor perfor-
mance in patients with schizophrenia, their relatives, and
healthy controls. Psychiatry Res. 1999;86:113–129.
10. Rubin P, Vorstrup S, Hemmingsen R, et al. Neurological
abnormalities in patients with schizophrenia or schizophreni-
form disorder at first admission to hospital: correlation with
computerised tomography and regional cerebral blood flow
findings. Acta Psychiatr Scand. 1994;90:385–390.
11. Heinrichs DW, Buchanan RW. The significance and meaning
of neurological signs in schizophrenia. Am J Psychiatry.
1988;145:11–18.
12. Nasrallah HA, Tippin J, McCalley-Whitters M. Neurological
soft signs in manic patients: a comparison with schizophrenic
control groups. J Aff Disord. 1983;5:45–50.
13. Bolton D, Gibb W, Lees A, et al. Neurological soft signs in
obsessive compulsive disorder: standardized assessment and
comparison with schizophrenia. Behav Neurol. 1998;11:
197–204.
14. Kinney DK, Yurgelun-Todd DA, Woods BT. Neurologic
signs of cerebellar and cortical sensory dysfunction in
schizophrenics and their relatives. Schizophr Res. 1999;
35:99–104.
15. Krebs MO, Gut-Fayand A, Bourdel MC, Dischamp J, Olie
JP. Validation and factorial structure of a standardized neu-
rological examination assessing neurological soft signs in
schizophrenia. Schizophr Res. 2000;45:245–260.
16. Woods BT, Kinney DK, Yurgelun-Todd D. Neurological
abnormalities in schizophrenic patients and their families. I.
comparison of schizophrenic, bipolar, substance-abuse
patients and normal control. Arch Gen Psychiatry 1986;43:
657–663.
17. Kinney DK, Woods BT, Yurgelun-Todd MA. Neurological
abnormalities in schizophrenic patients and their families.
Arch Gen Psychiatry. 1986;43:665–668.
18. Griffiths TD, Sigmundsson T, Takei N, et al. Neurological
abnormalities in familial and sporadic schizophrenia. Brain.
1998;121:191–203.
19. Niethammer R, Weisbrod M, Scheisser S, et al. Genetic
influence on laterality in schizophrenia? a twin study of
neurological soft signs. Am J Psychiatry. 2000;157:
272–274.
20. Yazici AH, Demir B, Yazici KM, Gogus A. Neurological soft
signs in schizophrenic patients and their nonpsychotic sib-
lings. Schizophr Res. 2002;58:241–246.
21. Fish B, Hagin R. Visual motor disorders in infants at risk for
schizophrenia. Arch Gen Psychiatry. 1973;28:900–904.
22. Marcus J, Hans SL, Lewow E, et al. Neurological findings in
high risk children: childhood assessment and 5-year follow
up. Schizophr Bull. 1985;11:85–100.
23. Carr V, Halpin S, Lau N, et al. A risk factor screening and
assessment protocol for schizophrenia and related psychosis.
Aust N Z J Psychiatry. 2000;34(suppl):s170–s180.
24. Buchanan RW, Heinrichs DW. The Neurological Evaluation
Scale (NES): a structured instrument for the assessment of
neurological signs in schizophrenia. Psychiatry Res. 1989;27:
335–350.
25. Mason O, Claridge G, Jackson M. New scales for the assess-
ment of schizotypy. Pers Individ Dif. 1995;18:7–13.
26. Launay G, Slade P. The measurement of hallucinatory pre-
disposition in male and female prisoners. Pers Individ Dif.
1981;2:221–234.
27. Barkus EJ, Stirling J, Hopkins RS, Lewis S. Cannabis-
induced psychotic-like experiences are associated with high
schizotypy. Psychopathology. In press.
28. Ismail BT, Cantor-Graae E, Cardenal S, McNeil TF.
Neurological abnormalities in schizophrenia: clinical, aetiol-
ogy, and demographic correlates. Schizophr Res. 1998;
30:229–238.
29. Lawrie SM, Byrne M, Miller P, et al. Neurodevelopmental
indices and the development of psychotic symptoms in sub-
jects at high risk of schizophrenia. Br J Psychiatry. 2001;178:
524–530.
30. Arango C, Bartko JJ, Gold JM, Buchanan RW. Prediction of
neurological performance by neurological signs in schizophre-
nia. Am J Psychiatry. 1999;156:1349–1357.
31. Gourian D, Goldberger C, Olie JP, Loo H, Krebs MO.
Neurological and morphological anomalies and the genetic
liability to schizophrenia: a composite phenotype. Schizophr
Res. 2004;67:23–31.
576
E. Barkus et al.32. Squires-Wheeler E, Skodol AE, Erlenmeyer-Kimling L. The
assessment of schizotypal features over two points in time.
Schizophr Res. 1991;6:75–85.
33. Chapman LJ, Chapman JP, Kwapil TR, Eckbald M, Zinser
MC. Putatively psychosis prone subjects ten years later.
J Abnorm Psychol. 1994;103:171–183.
34. Breslau N, Chilcoat HD, Johnstone EO, Andreski P, Lucia
VC. Neurological soft signs and low birth weight: their asso-
ciation and neuropsychiatric implications. Biol Psychiatry.
2000;47:71–79.
35. Tandon A, Kumari S, Ramiji S, Malik A, Singh S, Nigam
VR. Intellectual psycho-education and function status of
low birth weight survivors beyond five years of age. Indian
J Pediatr. 2000;67:791–796.
36. Gureje O. Neurological soft signs in Nigerian schizophrenics:
a controlled study. Acta Psychiatr Scand. 1988;78:505–509.
37. Lane A, Colgan K, Moynihan F, et al. Schizophrenia and
neurological soft signs: gender differences in clinical correlates
and antecedent factors. Psychiatry Res. 1996;64:105–114.
38. Cantor-Graae E, Ismail B, McNeil TF. Are neurological
abnormalities in schizophrenia patients and their siblings
the result of perinatal trauma? Acta Psychiatr Scand. 2000;
101:142–147.
39. Lesak SJ, Done DJ, Crow TJ. Adult psychosis, common
childhood infection and neurological soft signs in a national
birth cohort. Br J Psychiatry. 2002;181:387–392.
40. Lautenschlager NT, Wu JS, Law SM, et al. Neurological soft
signs are associated with APOE genotype, age, and cognitive
performance. J Alzheimers Dis. 2005;7:325–330.
41. Reiss AB. Cholesterol and apolipoprotein E in Alzheimer’s
disease. Am J Alzheimers Dis Other Demen. 2005;20:
91–96.
577
Neurological Soft Signs and Psychosis Proneness